Lackner, C; Gouw, ASH; Tiniakos, DG.
Reply to "MASLD fibrosis stage F3 is morphologically and transcriptomically diverse: implications for assessing therapeutic response" by Chaoyi Li, Quan H. Nguyen, Katharine Irvine, Elizabeth E. Powell, Andrew Clouston.
J Hepatol. 2026;
Doi: 10.1016/j.jhep.2025.12.020
PubMed
FullText
FullText_MUG